Aarthi Shenoy is an Oncology physician affiliated with Washington Hospital. OpenAlex indexes 82 publications with 1,635 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
110 Irving St NW # 2a38
Washington, DC 200103017
Telephone
202-877-2844Registry record last updated 18 Apr 2011.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20253 payments
- Celgene CorporationProgram year20252 payments
- Caris MPI, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59.9%Thalidomide Analog25.2%Pomalyst70%Lenalidomide15%Revlimid15%Part D<11 patientsKinase inhibitor10.5%Brukinsa41%Calquence30%Iclusig30%Part D<11 patients+ 4 more classes in this area
Nervous system
13.5%Opioid Agonist13.5%Methadone Hcl40%Oxycodone Hcl37%Oxycodone-Acetaminophen23%Part D<11 patientsDermatology
10.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor10.2%Acyclovir100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections
The Journal of Infectious Diseases
2023 - COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
Microbiology Spectrum
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”